Clinical and biochemical effects of stanozolol therapy for hereditary angioedema.

[1]  E. Brown,et al.  Long-term therapy of hereditary angioedema with danazol. , 1980, Annals of internal medicine.

[2]  M. Cicardi,et al.  Danazol and stanozolol in long-term prophylactic treatment of hereditary angioedema. , 1980, The Journal of allergy and clinical immunology.

[3]  A. Sheffer,et al.  Clinical and biochemical effects of impeded androgen (oxymetholone) therapy of hereditary angioedema. , 1979, The Journal of allergy and clinical immunology.

[4]  R. Wyatt,et al.  Remissions induced in hereditary angioneurotic edema with an attenuated androgen (danazol): correlation between concentrations of C1-inhibitor and the forth and second components of complement. , 1978, The Journal of laboratory and clinical medicine.

[5]  C. Johnson,et al.  Correlation of splenomegaly and abnormal neutrophil pooling (margination). , 1978, Journal of Laboratory and Clinical Medicine.

[6]  Daniel J. Gould,et al.  ANABOLIC STEROIDS IN HEREDITARY ANGIOŒDEMA , 1978, The Lancet.

[7]  I. Murray-Lyon,et al.  LIVER DAMAGE FROM LONG-TERM METHYLTESTOSTERONE , 1977, The Lancet.

[8]  A. Sheffer,et al.  Methyltestosterone therapy in hereditary angioedema. , 1977, Annals of internal medicine.

[9]  D. Alling,et al.  Treatment of hereditary angioedema with danazol. Reversal of clinical and biochemical abnormalities. , 1976, The New England journal of medicine.

[10]  M. Frank,et al.  The effect of synthetic androgens in hereditary angioneurotic edema: alteration of C1 inhibitor and C4 levels. , 1976, Transactions of the Association of American Physicians.

[11]  A. Sheffer,et al.  Tranexamic acid therapy in hereditary angioneurotic edema. , 1972, The New England journal of medicine.

[12]  J. C. Warren,et al.  Induction of premature menstruation with catatoxic steroids. , 1971, American Journal of Obstetrics and Gynecology.

[13]  I. Gigli,et al.  The stoichiometric measurement of the serum inhibition of the first component of complement by the inhibition of immune hemolysis. , 1968, Journal of immunology.

[14]  S. Ruddy,et al.  A stoichiometric assay for the fourth component of complement in whole human serum using EAC'la-gp and functionally pure human second component. , 1967, Journal of immunology.

[15]  J. Worley,et al.  Study of an anabolic steroid. Certain effects of oxymetholone on small children. , 1967, American journal of diseases of children.

[16]  F. Rosen,et al.  Hereditary Angioneurotic Edema: Two Genetic Variants , 1965, Science.

[17]  A. Beyer,et al.  EVALUATION OF THE ANABOLIC, HORMONAL, HEMATOPOIETIC, AND PATHOLOGIC PROPERTIES OF STANOZOLOL. , 1963, Experimental and molecular pathology. Supplement.

[18]  R. R. Evans,et al.  A BIOCHEMICAL ABNORMALITY IN HEREDIATRY ANGIONEUROTIC EDEMA: ABSENCE OF SERUM INHIBITOR OF C' 1-ESTERASE. , 1963, The American journal of medicine.

[19]  N. S. Landerman.  Hereditary angioneurotic edema. I. Case reports and review of the literature. , 1962, The Journal of allergy.

[20]  R. P. Howard,et al.  Metabolic and serum lipid effects of methylandrostane and methylandrostene pyrazoles. , 1962, The Journal of clinical endocrinology and metabolism.

[21]  W. Spaulding,et al.  METHYLTESTOSTERONE THERAPY FOR HEREDITARY EPISODIC EDEMA (HEREDITARY ANGIONEUROTIC EDEMA) , 1960 .

[22]  W. Osler.  HEREDITARY ANGIO‐NEUROTIC ŒDEMA , 1888 .